| |
Total (n = 1143)
|
PP (−) (n = 260)
|
PP (+) (n = 883)
|
P
|
|---|
|
Age, years
|
60.7 ± 9.3
|
58.7 ± 9.6
|
61.3 ± 9.1
|
< 0.001
|
|
Male, n (%)
|
624 (54.6)
|
122 (46.9)
|
502 (56.9)
|
0.005
|
|
Systolic BP, mmHg
|
126.1 ± 16.6
|
123.7 ± 16.3
|
126.8 ± 16.6
|
0.011
|
|
Diastolic BP, mmHg
|
77.0 ± 10.6
|
75.9 ± 11.1
|
77.3 ± 10.5
|
0.079
|
|
BMI, kg/m2
|
24.8 ± 3.0
|
24.3 ± 3.0
|
25.0 ± 3.0
|
0.002
|
|
BMI ≥ 25.0 kg/m2, n (%)
|
493 (43.9)
|
97 (37.5)
|
396 (45.8)
|
0.017
|
|
Hypertension, n (%)
|
674 (59.0)
|
123 (47.3)
|
551 (62.5)
|
< 0.001
|
|
Diabetes, n (%)
|
319 (27.9)
|
48 (18.5)
|
271 (30.7)
|
< 0.001
|
|
Hyperlipidemia, n (%)
|
381 (33.3)
|
69 (26.5)
|
312 (35.4)
|
0.008
|
|
Current smoking, n (%)
|
213 (18.6)
|
42 (16.2)
|
171 (19.4)
|
0.239
|
|
Medications, n (%)
|
|
Aspirin
|
555 (48.6)
|
107 (41.2)
|
448 (50.8)
|
0.006
|
|
Beta blocker
|
353 (31.0)
|
81 (31.2)
|
272 (30.9)
|
0.940
|
|
ACEI/ARB
|
389 (34.2)
|
67 (25.9)
|
332 (36.6)
|
0.001
|
|
Statin
|
520 (45.5)
|
89 (34.2)
|
431 (49.5)
|
< 0.001
|
|
Insulin therapy
|
33 (2.9)
|
5 (2.0)
|
28 (3.2)
|
0.294
|
|
Total cholesterol, mg/dL
|
182.6 ± 38.4
|
184.4 ± 39.6
|
182.0 ± 38.1
|
0.393
|
|
Triglyceride, mg/dL
|
143.3 ± 83.1
|
132.8 ± 73.9
|
146.4 ± 85.4
|
0.020
|
|
HDL-C, mg/dL
|
48.7 ± 12.3
|
50.3 ± 12.8
|
48.2 ± 12.1
|
0.016
|
|
LDL-C, mg/dL
|
111.5 ± 34.1
|
113.5 ± 34.2
|
110.9 ± 34.0
|
0.289
|
|
Creatinine, mg/dL
|
1.01 ± 0.67
|
0.96 ± 0.47
|
1.01 ± 0.72
|
0.233
|
|
FBG, mg/dL
|
110.7 ± 35.0
|
104.2 ± 28.6
|
112.7 ± 36.5
|
< 0.001
|
|
HbA1c, %
|
6.46 ± 1.27
|
6.26 ± 1.19
|
6.51 ± 1.28
|
0.067
|
|
TyG index
|
8.81 ± 0.59
|
8.69 ± 0.55
|
8.85 ± 0.60
|
< 0.001
|
- Values are presented as mean ± standard deviation or number (%)
- ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, BMI body mass index, BP blood pressure, FBG fasting blood glucose, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TyG triglyceride glucose
